Psea, - what you will like the company to PR ?

"Patient doing very well , don't need carboplatin , but FDA requested , with carboplatin or nothing ?"

You know they cant say that and survive as biotech ...

This is why they just said , patient missed one dose..What else they could say..everything else will be a lie...

I am sure you want this patient to continue taking Leronlimab , she need that for her life now...

I think I can imagine how Dr NP must feel , he knows all this , and must smile and complement FDA...

He knows that oncologist knows the best what his patient need ...


But for now we have to do , what we have to do..

I agree with you.
You want to be upset , try to change most of the FDA rules , go after them...
but here we need to finish for now ...



IMO as always...